Gordon Ingle

1.5k total citations
28 papers, 966 citations indexed

About

Gordon Ingle is a scholar working on Pathology and Forensic Medicine, Neurology and Molecular Biology. According to data from OpenAlex, Gordon Ingle has authored 28 papers receiving a total of 966 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pathology and Forensic Medicine, 8 papers in Neurology and 6 papers in Molecular Biology. Recurrent topics in Gordon Ingle's work include Multiple Sclerosis Research Studies (12 papers), Peripheral Neuropathies and Disorders (5 papers) and Neurological disorders and treatments (3 papers). Gordon Ingle is often cited by papers focused on Multiple Sclerosis Research Studies (12 papers), Peripheral Neuropathies and Disorders (5 papers) and Neurological disorders and treatments (3 papers). Gordon Ingle collaborates with scholars based in United Kingdom, Italy and United States. Gordon Ingle's co-authors include David H. Miller, Alan J. Thompson, Jaume Sastre‐Garriga, Mara Cercignani, Declan Chard, Lluís Ramió‐Torrentà, Jorge Sepulcre, Valerie L. Stevenson, Mary A. McLean and Massimo Filippi and has published in prestigious journals such as SHILAP Revista de lepidopterología, NeuroImage and Brain.

In The Last Decade

Gordon Ingle

26 papers receiving 941 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gordon Ingle United Kingdom 15 698 333 248 203 149 28 966
Christina Azevedo United States 17 920 1.3× 432 1.3× 218 0.9× 175 0.9× 116 0.8× 28 1.2k
Zhaleh Khaleeli United Kingdom 19 892 1.3× 277 0.8× 271 1.1× 302 1.5× 104 0.7× 27 1.1k
Nadir Abdelrahman United States 14 814 1.2× 233 0.7× 202 0.8× 185 0.9× 91 0.6× 30 1.1k
Christopher W. Tjoa United States 10 819 1.2× 259 0.8× 232 0.9× 272 1.3× 175 1.2× 14 1.0k
Rozie Arnaoutelis Canada 5 546 0.8× 221 0.7× 144 0.6× 174 0.9× 149 1.0× 6 795
Claudia Chien Germany 17 594 0.9× 412 1.2× 212 0.9× 139 0.7× 129 0.9× 61 966
Flavia Nelson United States 16 873 1.3× 348 1.0× 241 1.0× 356 1.8× 113 0.8× 49 1.2k
Joseph Kuchling Germany 16 638 0.9× 339 1.0× 214 0.9× 198 1.0× 111 0.7× 43 880
Seth A. Smith United States 14 619 0.9× 183 0.5× 173 0.7× 373 1.8× 132 0.9× 25 1.1k
Marzia Mortilla Italy 18 693 1.0× 343 1.0× 242 1.0× 177 0.9× 420 2.8× 50 1.4k

Countries citing papers authored by Gordon Ingle

Since Specialization
Citations

This map shows the geographic impact of Gordon Ingle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gordon Ingle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gordon Ingle more than expected).

Fields of papers citing papers by Gordon Ingle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gordon Ingle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gordon Ingle. The network helps show where Gordon Ingle may publish in the future.

Co-authorship network of co-authors of Gordon Ingle

This figure shows the co-authorship network connecting the top 25 collaborators of Gordon Ingle. A scholar is included among the top collaborators of Gordon Ingle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gordon Ingle. Gordon Ingle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sander, Laura, Gordon Ingle, Patricia McNamara, et al.. (2025). Role of ambulatory blood pressure monitoring as a non-invasive autonomic screening tool in hereditary transthyretin amyloidosis. Journal of Neurology Neurosurgery & Psychiatry. 97(3). jnnp–2025.
2.
Vichayanrat, Ekawat, Gordon Ingle, Patricia McNamara, et al.. (2025). Pure autonomic failure: a natural history study of the Queen Square cohort. Brain. 149(2). 606–619. 1 indexed citations
3.
Record, Christopher J., Mariola Skorupinska, Alexander M. Rossor, et al.. (2025). Heterozygous PNPT1 Variants Cause a Sensory Ataxic Neuropathy. European Journal of Neurology. 32(2). e70064–e70064.
4.
Stancanelli, Claudia, Ekawat Vichayanrat, Laura Sander, et al.. (2024). Cardiovascular autonomic failure in hereditary transthyretin amyloidosis and TTR carriers is an early and progressive disease marker. Clinical Autonomic Research. 34(3). 341–352. 4 indexed citations
5.
Vichayanrat, Ekawat, Laura Davis, Gordon Ingle, et al.. (2023). Abnormal dopamine transporter imaging in pure autonomic failure: a potential biomarker of central nervous system involvement. European Journal of Neurology. 31(3). e16169–e16169. 3 indexed citations
6.
Goh, Yee Yen, Jack Goodall, Gordon Ingle, et al.. (2022). 037  New insight into dysautonomia in GFAP astrocytopathy. Journal of Neurology Neurosurgery & Psychiatry. 93(6). A112.2–A112. 1 indexed citations
7.
Vichayanrat, Ekawat, Jalesh N. Panicker, Bethan Lang, et al.. (2021). Multimodal Biomarkers Quantify Recovery in Autoimmune Autonomic Ganglionopathy. Annals of Neurology. 89(4). 753–768. 20 indexed citations
8.
Bódi, István, Ellen Merete Hagen, Gordon Ingle, & Michael P. Lunn. (2020). Fatal autonomic failure due to premanifesting Parkinson's disease only diagnosed at autopsy. SHILAP Revista de lepidopterología. 8(10). 1997–1999. 1 indexed citations
9.
Berner, Alison, Claudia Craven, Faidra Laskou, et al.. (2016). Quality improvement: audio-visual tools are a valuable supplement when obtaining consent for lumbar punctures. PubMed. 3(3). 161–164. 3 indexed citations
10.
Klepacki, Jacek, Jost Klawitter, Jelena Klawitter, et al.. (2016). Amino acids in a targeted versus a non-targeted metabolomics LC-MS/MS assay. Are the results consistent?. Clinical Biochemistry. 49(13-14). 955–961. 35 indexed citations
11.
Craven, Claudia, et al.. (2016). Lumbar puncture: low-cost interventions improve efficiency and patient experience. Clinical Medicine. 16(3). s2–s2. 1 indexed citations
12.
Davies, G., Sarosh R. Irani, Cordelia Coltart, et al.. (2010). Anti-N-methyl-D-aspartate receptor antibodies: A potentially treatable cause of encephalitis in the intensive care unit. Critical Care Medicine. 38(2). 679–682. 65 indexed citations
13.
Sepulcre, Jorge, Jaume Sastre‐Garriga, Mara Cercignani, et al.. (2006). Regional gray matter atrophy in early primary progressive multiple sclerosis: a voxel-based morphometry study.. PubMed. 63(8). 1175–80. 140 indexed citations
14.
Stevenson, Valerie L., Alan J. Thompson, Gordon Ingle, et al.. (2005). A longitudinal study of cognition in primary progressive multiple sclerosis. Brain. 128(12). 2891–2898. 77 indexed citations
15.
Sastre‐Garriga, Jaume, Gordon Ingle, Declan Chard, et al.. (2005). Grey and white matter volume changes in early primary progressive multiple sclerosis: a longitudinal study. Brain. 128(6). 1454–1460. 113 indexed citations
16.
Karrenbauer, Virginija Danylaité, Valerio Leoni, Gavin Giovannoni, et al.. (2005). Plasma cerebrosterol and magnetic resonance imaging measures in multiple sclerosis. Clinical Neurology and Neurosurgery. 108(5). 456–460. 31 indexed citations
17.
Sastre‐Garriga, Jaume, Gordon Ingle, Declan Chard, et al.. (2005). Metabolite Changes in Normal-Appearing Gray and White Matter Are Linked With Disability in Early Primary Progressive Multiple Sclerosis. Archives of Neurology. 62(4). 569–569. 90 indexed citations
18.
Sastre‐Garriga, Jaume, Gordon Ingle, Declan Chard, et al.. (2004). Grey and white matter atrophy in early clinical stages of primary progressive multiple sclerosis. NeuroImage. 22(1). 353–359. 70 indexed citations
19.
Stevenson, Valerie L., Gordon Ingle, David H. Miller, & Alan J. Thompson. (2004). Magnetic resonance imaging predictors of disability in primary progressive multiple sclerosis: a 5-year study. Multiple Sclerosis Journal. 10(4). 398–401. 20 indexed citations
20.
Ingle, Gordon. (2003). Primary progressive multiple sclerosis: a 5-year clinical and MR study. Brain. 126(11). 2528–2536. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christina Azevedo Breakdown of academic impact, for papers by Zhaleh Khaleeli Breakdown of academic impact, for papers by Nadir Abdelrahman Breakdown of academic impact, for papers by Christopher W. Tjoa Breakdown of academic impact, for papers by Rozie Arnaoutelis Breakdown of academic impact, for papers by Claudia Chien Breakdown of academic impact, for papers by Flavia Nelson Breakdown of academic impact, for papers by Joseph Kuchling Breakdown of academic impact, for papers by Seth A. Smith Breakdown of academic impact, for papers by Marzia Mortilla
Rankless by CCL
2026